Biovest completes BiovaxID manufacturing site construction
The new manufacturing site is a part of an expansion project within Biovest’s 35,000sqft cell culture center in Coon Rapids. The new expanded facility will manufacture Biovest’s late-stage,
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.